Oncogene - Table of Contents alert Volume 36 Issue 20

If you are unable to see the message below, click here to view.

Advertisement New: Diagenode Epigenomic Profiling Services Complete chromatin modification and DNA methylation analysis with bioinformatics Choice in level of service: complete or partial Expertise in low input samples Fast results typically in 8-10 weeks at a low cost Learn more about our Epigenomic Profiling Services TABLE OF CONTENTS Volume 36, Issue 20 (May 2017) In this issue Original Articles Short Communication Retraction Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Original Articles Top Androgen and AR contribute to breast cancer development and metastasis: an insight of mechanisms J Feng, L Li, N Zhang, J Liu, L Zhang, H Gao, G Wang, Y Li, Y Zhang, X Li, D Liu, J Lu and B Huang Oncogene 2017 36: 2775-2790; advance online publication, November 28, 2016; 10.1038/onc.2016.432 Abstract | Full Text MUC1-C activates BMI1 in human cancer cells M Hiraki, T Maeda, A Bouillez, M Alam, A Tagde, K Hinohara, Y Suzuki, T Markert, M Miyo, K Komura, R Ahmad, H Rajabi and D Kufe Oncogene 2017 36: 2791-2801; advance online publication, November 28, 2016; 10.1038/onc.2016.439 Abstract | Full Text DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer OPEN Y M Choi, K B Kim, J H Lee, Y K Chun, I S An, S An and S Bae Oncogene 2017 36: 2802-2812; advance online publication, December 12, 2016; 10.1038/onc.2016.441 Abstract | Full Text TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression C Jiang, Y Zhu, Z Zhou, J Gumin, L Bengtsson, W Wu, Z Songyang, F F Lang and X Lin Oncogene 2017 36: 2813-2823; advance online publication, December 19, 2016; 10.1038/onc.2016.430 Abstract | Full Text The induction of MIG6 under hypoxic conditions is critical for dormancy in primary cultured lung cancer cells with activating EGFR mutations H Endo, J Okami, H Okuyama, Y Nishizawa, F Imamura and M Inoue Oncogene 2017 36: 2824-2834; advance online publication, November 28, 2016; 10.1038/onc.2016.431 Abstract | Full Text Phosphorylation of NFAT3 by CDK3 induces cell transformation and promotes tumor growth in skin cancer OPEN T Xiao, J J Zhu, S Huang, C Peng, S He, J Du, R Hong, X Chen, A M Bode, W Jiang, Z Dong and D Zheng Oncogene 2017 36: 2835-2845; advance online publication, November 28, 2016; 10.1038/onc.2016.434 Abstract | Full Text Cooperation among heterogeneous prostate cancer cells in the bone metastatic niche K Shahriari, F Shen, A Worrede-Mahdi, Q Liu, Y Gong, F U Garcia and A Fatatis Oncogene 2017 36: 2846-2856; advance online publication, December 19, 2016; 10.1038/onc.2016.436 Abstract | Full Text Evolution and heterogeneity of non-hereditary colorectal cancer revealed by single-cell exome sequencing H Wu, X-Y Zhang, Z Hu, Q Hou, H Zhang, Y Li, S Li, J Yue, Z Jiang, S M Weissman, X Pan, B-G Ju and S Wu Oncogene 2017 36: 2857-2867; advance online publication, December 12, 2016; 10.1038/onc.2016.438 Abstract | Full Text Inhibition of KPNA4 attenuates prostate cancer metastasis J Yang, C Lu, J Wei, Y Guo, W Liu, L Luo, G Fisch and X Li Oncogene 2017 36: 2868-2878; advance online publication, December 12, 2016; 10.1038/onc.2016.440 Abstract | Full Text Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K→AKT→GSK3β→AM signaling OPEN Y Chen, C Li, H Xie, Y Fan, Z Yang, J Ma, D He and L Li Oncogene 2017 36: 2879-2888; advance online publication, January 23, 2017; 10.1038/onc.2016.442 Abstract | Full Text Intracellular IL-37b interacts with Smad3 to suppress multiple signaling pathways and the metastatic phenotype of tumor cells C Luo, Y Shu, J Luo, D Liu, D-S Huang, Y Han, C Chen, Y-C Li, J-M Zou, J Qin, Y Wang, D Li, S-S Wang, G-M Zhang, J Chen and Z-H Feng Oncogene 2017 36: 2889-2899; advance online publication, January 16, 2017; 10.1038/onc.2016.444 Abstract | Full Text Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity D Zhang, N Jin, W Sun, X Li, B Liu, Z Xie, J Qu, J Xu, X Yang, Y Su, S Tang, H Han, D Chen, J Ding, M Tan, M Huang and M Geng Oncogene 2017 36: 2900-2909; advance online publication, December 19, 2016; 10.1038/onc.2016.446 Abstract | Full Text Short Communication Top Identification of MYST3 as a novel epigenetic activator of ERα frequently amplified in breast cancer OPEN L Yu, Y Liang, X Cao, X Wang, H Gao, S-Y Lin, R Schiff, X-S Wang and K Li Oncogene 2017 36: 2910-2918; advance online publication, November 28, 2016; 10.1038/onc.2016.433 Abstract | Full Text Retraction Top Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to 20S proteasomal degradation of p63 resulting in thinning of epithelium and chemical-induced skin cancer B A Patrick, X Gong and A K Jaiswal Oncogene 2017 36: 2919; advance online publication, March 6, 2017; 10.1038/onc.2016.475 Full Text Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer B A Patrick and A K Jaiswal Oncogene 2017 36: 2920; advance online publication, March 6, 2017; 10.1038/onc.2016.476 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.